Therapeutic methods using anti-cd200 antibodies
US-2016009803-A1 · Jan 14, 2016 · US
US10214765B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10214765-B2 |
| Application number | US-201815881581-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 26, 2018 |
| Priority date | Aug 18, 2012 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are compounds for use as sialidase inhibitors, including alkynyl-3-fluorosialyl fluoride. The compounds, which include the compound DFSA, function by trapping a 3-fluorosialylenzyme intermediate (reporter-inhibitor-enzyme conjugate). These compounds can be conjugated with a detectable tagging moiety for isolation and identification of sialidases.
Opening claim text (preview).
We claim: 1. A compound of formula (I): or a salt thereof, wherein F atom at the C3-position is axial or equatorial; R 1 is H or C 1-6 alkyl; R 2 is OR 2O , N 3 , N(R 2N ) 2 , or —NH(C═NH)NH 2 ; each instance of R 2O is independently hydrogen, C 1-6 alkyl, acyl, or a hydroxyl protecting group; each instance of R 2N is independently hydrogen, C 1-6 alkyl, acyl, or an amine protecting group; each instance of R 3a and R 3b is independently hydrogen, —C(═O)—R 3r , or a hydroxyl protecting group; each instance of R 3r is C 1-6 alkyl, aryl, heteroaryl, heterocyclyl, alkylaryl, alkylheteroaryl, or alkylheterocyclyl; X is selected from the group consisting of —O—, —O(C═O)—, —NH—, —NH(C═O)—, —(C═O)NH—, —O(C═O)NH—, —O(C═S)NH—, —NH(C═O)NH—, and —NH(C═S)NH—; R 4 is H, C 1-6 alkyl, or -L-Z; Y is CF 3 , C 1-6 alkyl or -L-Z; each instance of L is independently selected from the group consisting of —(CH 2 ) n —, —(CH 2 ) n C═O—, —(CH 2 ) n NH—, —(C═O)(CH 2 ) n —, —(CH 2 ) n NH(C═O)—, —(C═O)(CH 2 ) n NH(C═O)—, —(CH 2 ) n SCH 2 (C═O)—, and —(CH 2 CH 2 O) n —; each instance of n is an integer from 1 to 8, inclusive; each instance of Z is alkynyl, alkenyl, halogen, N(R N ) 2 , OR O , SR S , or CO 2 R O ; each instance of R N is independently hydrogen, C 1-6 alkyl, acyl, or an amine protecting group; each instance of R O is independently hydrogen, C 1-6 alkyl, acyl, or a hydroxyl protecting group; each instance of R S is independently hydrogen, C 1-6 alkyl, or a thiol protecting group; provided that the compound is not of the formula provided that when R 4 is -L-Z, Y is C 1-6 alkyl; and provided that when Y is -L-Z, R 4 is H or C 1-6 alkyl. 2. The compound of claim 1 of formula (II-a): or a salt thereof, wherein R 3c is independently hydrogen, C 1-6 alkyl, acyl, or a hydroxyl protecting group. 3. The compound of claim 2 of formula (II-b): or a salt thereof. 4. The compound of claim 3 , having a formula (II-b1): or a salt thereof. 5. The compound of claim 4 , having the formula (II-b2): wherein R y1 is hydrogen, halogen, or C 1-6 alkyl, or a salt thereof. 6. The compound of claim 1 of formula (II-c): or a salt thereof. 7. The compound of claim 6 , having a formula selected from (II-c1) and (II-C2): wherein R y2 is hydrogen or C 1-6 alkyl, or a salt thereof. 8. The compound of claim 6 , wherein Y is C 1-6 alkyl. 9. The compound of claim 8 , wherein Y is methyl or CF 3 . 10. The compound of claim 1 , wherein R 1 is H or methyl. 11. The compound of claim 1 , wherein the F atom at the C3-position is axial. 12. The compound of claim 1 , wherein the F atom at the C3-position is equatorial. 13. The compound of claim 1 , wherein R 3a is —C(═O)—R 3r , wherein R 3r is C 1-6 alkyl or aryl. 14. The compound of claim 1 , wherein R 3a is benzoyl. 15. The compound of claim 1 , wherein R 3a is CH 3 CO—, C 2 H 5 CO—, C 3 H 7 CO—, t-BuCO—, CF 3 CO—, PhCH 2 CO—, or C 6 H 5 CO—. 16. The compound of claim 1 , wherein the compound is one of the following formulae:
involving hydrolase · CPC title
Orthomyxoviridae, e.g. influenza virus · CPC title
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title
Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase · CPC title
Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.